These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16465578)

  • 41. A new approach for evaluating the resectability of pancreatic and periampullary neoplasms.
    Fang CH; Zhu W; Wang H; Xiang N; Fan Y; Yang J; Wang X; Zhong Sz
    Pancreatology; 2012; 12(4):364-71. PubMed ID: 22898639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of pancreatic head adenocarcinoma?
    Ellsmere J; Mortele K; Sahani D; Maher M; Cantisani V; Wells W; Brooks D; Rattner D
    Surg Endosc; 2005 Mar; 19(3):369-73. PubMed ID: 15624058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
    Lou FL; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement study.
    Kim HY; Lee YJ; Chang W; Cho J; Park JH; Lee JC; Kim J; Hwang JH; Kim YH
    Eur Radiol; 2022 Jun; 32(6):3799-3807. PubMed ID: 35032213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computed tomography and laparoscopy in the assessment of the patient with pancreatic cancer.
    Andrén-Sandberg A; Lindberg CG; Lundstedt C; Ihse I
    J Am Coll Surg; 1998 Jan; 186(1):35-40. PubMed ID: 9449598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [MRI in the evaluation of peripancreatic vessel invasion and resectability of pancreatic carcinoma].
    Wang DQ; Zeng MS; Jin DY; Lou WH; Ji Y; Rao SX; Shi X; Chen CZ; Li RC
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):846-9. PubMed ID: 18396644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
    Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
    AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.
    Kim YE; Park MS; Hong HS; Kang CM; Choi JY; Lim JS; Lee WJ; Kim MJ; Kim KW
    Radiology; 2009 Mar; 250(3):758-65. PubMed ID: 19164113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of pancreatic tumor resectability with multidetector computed tomography: semiautomated console-generated images versus dedicated workstation-generated images.
    Singh AK; Sahani DV; Blake MA; Joshi MC; Wargo JA; Fernandez-del Castillo C
    Acad Radiol; 2008 Aug; 15(8):1058-68. PubMed ID: 18620126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms.
    White R; Winston C; Gonen M; D'Angelica M; Jarnagin W; Fong Y; Conlon K; Brennan M; Allen P
    J Am Coll Surg; 2008 Mar; 206(3):445-50. PubMed ID: 18308214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative staging of periampullar cancer with US, CT, EUS and CA 19-9.
    Tomazic A; Pegan V
    Hepatogastroenterology; 2000; 47(34):1135-7. PubMed ID: 11020897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic performance of MDCT for predicting important prognostic factors in pancreatic cancer.
    Kim JH; Eun HW; Kim KW; Lee JY; Lee JM; Han JK; Choi BI
    Pancreas; 2013 Nov; 42(8):1316-22. PubMed ID: 24152957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: accuracy in the prediction of vascular invasion and resectability.
    Ahmed SA; Mourad AF; Hassan RA; Ibrahim MAE; Soliman A; Aboeleuon E; Elbadee OMA; Hetta HF; Jabir MA
    Abdom Radiol (NY); 2021 Jan; 46(1):280-289. PubMed ID: 32488556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TNM staging of pancreatic carcinoma using helical CT.
    Zeman RK; Cooper C; Zeiberg AS; Kladakis A; Silverman PM; Marshall JL; Evans SR; Stahl T; Buras R; Nauta RJ; Sitzmann JV; al-Kawas F
    AJR Am J Roentgenol; 1997 Aug; 169(2):459-64. PubMed ID: 9242754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.